Alzheimer's is the 6th leading cause of death in the US and every 67 seconds someone develops this disease. Women are the epicenter of the disease and 2/3 of Americans with the disease is a woman. An estimated 5.2 million Americans of all ages have Alzheimer's disease in 2014. This includes an estimated 5 million people age 65 and older, A1 and approximately 200,000 individuals under age 65 who have younger-onset Alzheimer's.
With these rates, scientists and well-renowned neurologists are looking for treatments in various fields of science. One of the most popular is Traditional Medicine. This technique uses physical techniques and organic means. The most used is organic medicine. Supplements had been developed to maintain neurologic health and attain optimum neurologic function for patients with Alzheimer's and those that are a high risk of developing the disease.
Among the most popular organic material used is Bacopa Monnieri. This ayurvedic plant had been tested by time and tradition to be a powerful neurologic enhancer and stabilizer. In this very scientific world that we have right now, studies and clinical trials arose to test and prove it's function and effectivity. This time-tested plant had undergone several clinical manipulations to prove it's a role in America's most widely known and prevalent neurologic disability, Alzheimer's disease.
According to one trial, Bacopa monniera attenuates scopolamine-induced impairment of spatial memory in mice. This suggests that B. monniera's effects on the cholinergic system may be helpful for developing alternative therapeutic approaches for the treatment of Alzheimer's disease. B. monniera had been used as well in elderly volunteers to determine the effect of B. monnieri on attention, cognitive processing, working memory, and cholinergic and monoaminergic functions. The trial suggests that B. monnieri can improve attention, cognitive processing, and working memory partly via the suppression of AChE activity.
